New stem cells that help repair lung damage in severe respiratory conditions

Novel intrinsic endothelial stem cells responsible for lung endothelial regeneration and vascular repair in ARDS

NIH-funded research Lurie Children's Hospital of Chicago · NIH-11003769

This study is looking at special stem cells that help heal lung damage from serious breathing problems like ARDS, especially after infections, to find new ways to treat patients who are struggling with this condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLurie Children's Hospital of Chicago NIH-funded
Lab location1 site (Chicago, United States)
Project IDNIH-11003769 on NIH RePORTER

What this research studies

This research investigates a unique type of endothelial stem cell that plays a crucial role in repairing lung damage caused by acute respiratory distress syndrome (ARDS). The study focuses on understanding how these stem cells contribute to lung endothelial regeneration after injury, particularly following sepsis. By examining both animal models and human patients, the researchers aim to identify the specific characteristics and functions of these cells, which could lead to new therapeutic strategies for ARDS. The approach involves detailed genetic analysis to uncover the mechanisms behind endothelial cell regeneration.

Who could benefit from this research

Good fit: Ideal candidates for this research include adults diagnosed with acute respiratory distress syndrome, particularly those who have experienced sepsis.

Not a fit: Patients with chronic respiratory conditions or those not experiencing acute lung injury may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that enhance lung repair and improve survival rates for patients suffering from ARDS.

How similar studies have performed: While the investigation of endothelial stem cells is a growing field, this specific focus on UC+ endothelial stem cells in the context of ARDS represents a novel approach.

Where this research is happening

Chicago, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acute Lung InjuryAcute Pulmonary InjuryAcute Respiratory Distress Syndromeacute respiratory distress syndrome caused by sepsis
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.